Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

Monica Fedele, Sabrina Battista, Lawrence Kenyon, Gustavo Baldassarre, Vincenzo Fidanza, Andres J P Klein-Szanto, A. F. Parlow, Rosa Visone, Giovanna M. Pierantoni, Eric Outwater, Massimo Santoro, Carlo M. Croce, Alfredo Fusco

Research output: Contribution to journalArticle

Abstract

Overexpression of the HMGA2 gene is a common feature of neoplastic cells both in experimental and human models. Intragenic and extragenic HMGA2 rearrangements responsible for HMGA2 gene over-expression have been frequently detected in human benign tumours of mesenchymal origin. To better understand the role of HMGA2 overexpression in human tumorigenesis, we have generated transgenic mice carrying the HMGA2 gene under the transcriptional control of the cytomegalovirus promoter. High expression of the transgene was demonstrated in all the mouse tissues analysed, whereas no expression of the endogenous HMGA2 gene was detected in the same tissues from wild-type mice. In this study, two indipendent lines of transgenic mice have been generated. By 6 months of age, 85% of female animals of both transgenic lines developed pituitary adenomas secreting prolactin and growth hormone. The transgenic males developed the same phenotype with a lower penetrance (40%) and a longer latency period (about 18 months). Therefore, these data demonstrate that the overexpression of HMGA2 leads to the onset of mixed growth hormone/prolactin cell pituitary adenomas. These transgenic mice may represent an important tool for the study of this kind of neoplasia.

Original languageEnglish
Pages (from-to)3190-3198
Number of pages9
JournalOncogene
Volume21
Issue number20
DOIs
Publication statusPublished - May 9 2002

Fingerprint

Pituitary Neoplasms
Transgenic Mice
Growth Hormone-Secreting Pituitary Adenoma
Genes
Genetically Modified Animals
Penetrance
Cytomegalovirus
Transgenes
Prolactin
Growth Hormone
Neoplasms
Carcinogenesis
Theoretical Models
Phenotype
Gene Expression

Keywords

  • Pit-1
  • Pituitary adenomas
  • Transgenic mice HMGA2
  • Tumorigenesis

ASJC Scopus subject areas

  • Molecular Biology
  • Cancer Research
  • Genetics

Cite this

Fedele, M., Battista, S., Kenyon, L., Baldassarre, G., Fidanza, V., Klein-Szanto, A. J. P., ... Fusco, A. (2002). Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. Oncogene, 21(20), 3190-3198. https://doi.org/10.1038/sj/onc/1205428

Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. / Fedele, Monica; Battista, Sabrina; Kenyon, Lawrence; Baldassarre, Gustavo; Fidanza, Vincenzo; Klein-Szanto, Andres J P; Parlow, A. F.; Visone, Rosa; Pierantoni, Giovanna M.; Outwater, Eric; Santoro, Massimo; Croce, Carlo M.; Fusco, Alfredo.

In: Oncogene, Vol. 21, No. 20, 09.05.2002, p. 3190-3198.

Research output: Contribution to journalArticle

Fedele, M, Battista, S, Kenyon, L, Baldassarre, G, Fidanza, V, Klein-Szanto, AJP, Parlow, AF, Visone, R, Pierantoni, GM, Outwater, E, Santoro, M, Croce, CM & Fusco, A 2002, 'Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas', Oncogene, vol. 21, no. 20, pp. 3190-3198. https://doi.org/10.1038/sj/onc/1205428
Fedele, Monica ; Battista, Sabrina ; Kenyon, Lawrence ; Baldassarre, Gustavo ; Fidanza, Vincenzo ; Klein-Szanto, Andres J P ; Parlow, A. F. ; Visone, Rosa ; Pierantoni, Giovanna M. ; Outwater, Eric ; Santoro, Massimo ; Croce, Carlo M. ; Fusco, Alfredo. / Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas. In: Oncogene. 2002 ; Vol. 21, No. 20. pp. 3190-3198.
@article{b1e70e4935b943c5a38113ea6084f3df,
title = "Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas",
abstract = "Overexpression of the HMGA2 gene is a common feature of neoplastic cells both in experimental and human models. Intragenic and extragenic HMGA2 rearrangements responsible for HMGA2 gene over-expression have been frequently detected in human benign tumours of mesenchymal origin. To better understand the role of HMGA2 overexpression in human tumorigenesis, we have generated transgenic mice carrying the HMGA2 gene under the transcriptional control of the cytomegalovirus promoter. High expression of the transgene was demonstrated in all the mouse tissues analysed, whereas no expression of the endogenous HMGA2 gene was detected in the same tissues from wild-type mice. In this study, two indipendent lines of transgenic mice have been generated. By 6 months of age, 85{\%} of female animals of both transgenic lines developed pituitary adenomas secreting prolactin and growth hormone. The transgenic males developed the same phenotype with a lower penetrance (40{\%}) and a longer latency period (about 18 months). Therefore, these data demonstrate that the overexpression of HMGA2 leads to the onset of mixed growth hormone/prolactin cell pituitary adenomas. These transgenic mice may represent an important tool for the study of this kind of neoplasia.",
keywords = "Pit-1, Pituitary adenomas, Transgenic mice HMGA2, Tumorigenesis",
author = "Monica Fedele and Sabrina Battista and Lawrence Kenyon and Gustavo Baldassarre and Vincenzo Fidanza and Klein-Szanto, {Andres J P} and Parlow, {A. F.} and Rosa Visone and Pierantoni, {Giovanna M.} and Eric Outwater and Massimo Santoro and Croce, {Carlo M.} and Alfredo Fusco",
year = "2002",
month = "5",
day = "9",
doi = "10.1038/sj/onc/1205428",
language = "English",
volume = "21",
pages = "3190--3198",
journal = "Oncogene",
issn = "0950-9232",
publisher = "Nature Publishing Group",
number = "20",

}

TY - JOUR

T1 - Overexpression of the HMGA2 gene in transgenic mice leads to the onset of pituitary adenomas

AU - Fedele, Monica

AU - Battista, Sabrina

AU - Kenyon, Lawrence

AU - Baldassarre, Gustavo

AU - Fidanza, Vincenzo

AU - Klein-Szanto, Andres J P

AU - Parlow, A. F.

AU - Visone, Rosa

AU - Pierantoni, Giovanna M.

AU - Outwater, Eric

AU - Santoro, Massimo

AU - Croce, Carlo M.

AU - Fusco, Alfredo

PY - 2002/5/9

Y1 - 2002/5/9

N2 - Overexpression of the HMGA2 gene is a common feature of neoplastic cells both in experimental and human models. Intragenic and extragenic HMGA2 rearrangements responsible for HMGA2 gene over-expression have been frequently detected in human benign tumours of mesenchymal origin. To better understand the role of HMGA2 overexpression in human tumorigenesis, we have generated transgenic mice carrying the HMGA2 gene under the transcriptional control of the cytomegalovirus promoter. High expression of the transgene was demonstrated in all the mouse tissues analysed, whereas no expression of the endogenous HMGA2 gene was detected in the same tissues from wild-type mice. In this study, two indipendent lines of transgenic mice have been generated. By 6 months of age, 85% of female animals of both transgenic lines developed pituitary adenomas secreting prolactin and growth hormone. The transgenic males developed the same phenotype with a lower penetrance (40%) and a longer latency period (about 18 months). Therefore, these data demonstrate that the overexpression of HMGA2 leads to the onset of mixed growth hormone/prolactin cell pituitary adenomas. These transgenic mice may represent an important tool for the study of this kind of neoplasia.

AB - Overexpression of the HMGA2 gene is a common feature of neoplastic cells both in experimental and human models. Intragenic and extragenic HMGA2 rearrangements responsible for HMGA2 gene over-expression have been frequently detected in human benign tumours of mesenchymal origin. To better understand the role of HMGA2 overexpression in human tumorigenesis, we have generated transgenic mice carrying the HMGA2 gene under the transcriptional control of the cytomegalovirus promoter. High expression of the transgene was demonstrated in all the mouse tissues analysed, whereas no expression of the endogenous HMGA2 gene was detected in the same tissues from wild-type mice. In this study, two indipendent lines of transgenic mice have been generated. By 6 months of age, 85% of female animals of both transgenic lines developed pituitary adenomas secreting prolactin and growth hormone. The transgenic males developed the same phenotype with a lower penetrance (40%) and a longer latency period (about 18 months). Therefore, these data demonstrate that the overexpression of HMGA2 leads to the onset of mixed growth hormone/prolactin cell pituitary adenomas. These transgenic mice may represent an important tool for the study of this kind of neoplasia.

KW - Pit-1

KW - Pituitary adenomas

KW - Transgenic mice HMGA2

KW - Tumorigenesis

UR - http://www.scopus.com/inward/record.url?scp=0037046499&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0037046499&partnerID=8YFLogxK

U2 - 10.1038/sj/onc/1205428

DO - 10.1038/sj/onc/1205428

M3 - Article

C2 - 12082634

VL - 21

SP - 3190

EP - 3198

JO - Oncogene

JF - Oncogene

SN - 0950-9232

IS - 20

ER -